Career and Life Achievements of Fortress Investment Group Principal, Peter Briger

Fortress Investment Group’s Board of Directors Co-Chairman and Principal, Peter Briger is a living legend in the alternative asset management sector. Today, he heads one of the best global management firms for alternative assets. His achievements and accomplishments in business through the years have earned him position 317 in the Forbes Top 400 Billionaires list. These are many spots up from No. 962 four years earlier. As a business leader, Peter is loved by his employees and colleagues. To them, he is famously known as Pete.

Mr. Briger at Fortress Investment

This accomplished alternative asset manager joined the Fortress Investment Group back in 2002 as a Management Committee member. He worked at this position diligently and was promoted to a Director position in 2006. In August 2009, he became the Board’s Co-Chairman, and soon after, he went ahead to become the Credit and Real Estate Head and principal at this firm.Before joining Fortress Investment Group, Peter Briger was working at Goldman Sachs for over 15 years. Here, he served as the Trading Businesses and Whole Loans Sales Co-head. He also worked in the same position in other departments including the Fixed Income Principal Investments Group, Asian Distressed Debt business and Asian Real Estate Private Equity business.

Prior to Goldman Sachs, The Fortress Investment Group Principal had worked at International Finance Corporation as a Distressed Debt Advisor. Early in his career, he was a member of Linktone Ltd. Advisory board. Academically, Mr. Briger attended Princeton University where he graduated with a B.A. He then joined University of Pennsylvania’s Wharton School of Business for his M.B.A. Apart from being a sharp business person, Peter is also a philanthropist. His philanthropic efforts are directed towards uplifting communities and promoting education. He is currently one of the biggest donors to the revolutionary Princeton Entrepreneurship program. As a financial investor, Peter Briger is dedicated to helping create professional and highly capable leaders for the business world.

Peter’s take on Bitcoins

It is no doubt the Bitcoin virtual currency is taking the world by a storm, and from its onset, Mr. Briger has been a big believer in its potential. Back in 2013, he and his Fortress Investment Group had a sit-down with the major American banks to discuss the direction and impact of bitcoins. He encouraged these banks to take Bitcoins seriously and be part of the movement to stay relevant in the future. Today, he still believes that Bitcoins are simply a digital goldmine. Peter Briger is leading other Wall Street giants over to this goldmine, and he has successfully impacted many.

Scott Rocklage | Renowned Life Science Doctor, and Investor

Scott Rocklage, Ph.D. started working at 5AM Ventures in 2003 as a Partner and rose to the role of Managing Partner a year later. Dr. Rocklage has a 30-year experience in healthcare management with tactical leadership roles that led to FDA approval of new drug applications (Teslascan® Omniscan™, and Cubicin®).

 

Dr. Rocklage has served as CEO and Chairman of Cubist Pharmaceuticals, CEO and President of Nycomed Salutar and also as R&D at Catalytica and Salutar. He previously served as Board Chairman of Relypsa and Novira. He currently serves as Board Chairman of Kinestral, Rennovia, and Cidara as well as Epirus and Pulmatrix. Dr. Rocklage was a former Management Chairman of Ilypsa (Amgen), Miikana (now EntreMed) and Semprus (Teleflex).

 

Dr. Scott Rocklage acquired his B.S. in Chemistry from UCB and his Chemistry Ph.D. from MIT, where he researched under the guidance of Richard R. Schrock (Nobel winner – 2005). He has invented over 30 government patents and reviewed over 100 peer-publications. Dr. Rocklage currently operates from his Boston, MA, office.

 

The Rocklages’ Unexpected Science Lab Gift

 

On July 18, 2016, Dr. Scott Rocklage was invited by his former Chemistry research institution. He was to celebrate the unexpected gift to the Chemistry Department in support of the renovation of Moungi Bawendi’s nanochemistry and nanotechnology lab space at MIT. Dr. Rocklage conducted his Ph.D. thesis in the Department of Chemistry under the guidance of Professor Richard R. Schrock, a 2005 Chemistry Nobel laureate.

 

Dr.Scott Rocklage and his wife Patty got a tour of the newly revamped lab space by a resident Professor Bawendi and a few graduate students. He was pleasantly surprised to find a plaque with his name inscribed on it at the Lab’s entrance. The entire chemistry department staff witnessed as Dr. Rocklage received accolades from the Bawendi members, former department heads Timothy Jamison, Sylvia Ceyer, and Prof. Moungi Bawendi.

5AM Ventures is a top investment firm whose aim is to build future science companies competent to deliver exceptional profits to investors. 5AM Ventures supports businesses that work to resolve healthcare needs through advanced research in medicine. The groups of companies involved lead with innovative approaches to recognize, avert and treat a broad range of health conditions.

 

5AM’s venture experts hold competitive financial, scientific, operational, medical, and legal skills. The balanced background gives the firm a unique advantage to discover and outline life science group companies. They employ seasoned, hands-on approach to growth and also get directly involved in applying business strategy, executive recruiting, and fundraising. The sitting board members regularly take on interim operating roles.

 

Dr.Scott Rocklage has spent his career in the life science profession, often working jointly with other like-minded peers to help generate shareholder value. As a board management leader, Dr. Rocklage draws over thirty years of CEO and added leadership roles at various science companies. He has proven to be fully capable of working with established investors, and co-investing with venture capitalists at major science companies.